Fig. 1From: Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trialStudy flow chart. DSA donor-specific antibody, eGFR estimated glomerular filtration rate, FU-Bx follow-up biopsy, KTX kidney transplantation, PD pharmacodynamics, PK pharmacokinetics, TTV Torque Teno virusBack to article page